165 related articles for article (PubMed ID: 34021128)
1. SPOP-PTEN-SUFU axis promotes progression of clear cell renal cell carcinoma via activating SHH and WNT pathway.
Han B; Sun Z; Yu T; Wang Y; Kuang L; Li T; Cai J; Cao Q; Xu Y; Gao B; Cheng SY; Yue S; Liu C
Cell Death Discov; 2021 May; 7(1):120. PubMed ID: 34021128
[TBL] [Abstract][Full Text] [Related]
2. Speckle-type POZ protein could play a potential inhibitory role in human renal cell carcinoma.
Chen Z; Li Z; Li C; Li B; Wang H; Nong D; Li X; Huang G; Lin J; Li W
BMC Cancer; 2022 Dec; 22(1):1277. PubMed ID: 36474188
[TBL] [Abstract][Full Text] [Related]
3. Spop regulates Gli3 activity and Shh signaling in dorsoventral patterning of the mouse spinal cord.
Cai H; Liu A
Dev Biol; 2017 Dec; 432(1):72-85. PubMed ID: 28412462
[TBL] [Abstract][Full Text] [Related]
4. SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer.
Li G; Ci W; Karmakar S; Chen K; Dhar R; Fan Z; Guo Z; Zhang J; Ke Y; Wang L; Zhuang M; Hu S; Li X; Zhou L; Li X; Calabrese MF; Watson ER; Prasad SM; Rinker-Schaeffer C; Eggener SE; Stricker T; Tian Y; Schulman BA; Liu J; White KP
Cancer Cell; 2014 Apr; 25(4):455-68. PubMed ID: 24656772
[TBL] [Abstract][Full Text] [Related]
5. The E2F1-miR-520/372/373-SPOP Axis Modulates Progression of Renal Carcinoma.
Ding M; Lu X; Wang C; Zhao Q; Ge J; Xia Q; Wang J; Zen K; Zhang CY; Zhang C
Cancer Res; 2018 Dec; 78(24):6771-6784. PubMed ID: 30348808
[TBL] [Abstract][Full Text] [Related]
6. Structure-Activity Relationship of SPOP Inhibitors against Kidney Cancer.
Dong Z; Wang Z; Guo ZQ; Gong S; Zhang T; Liu J; Luo C; Jiang H; Yang CG
J Med Chem; 2020 May; 63(9):4849-4866. PubMed ID: 32297747
[TBL] [Abstract][Full Text] [Related]
7. Sufu- and Spop-mediated regulation of Gli2 is essential for the control of mammalian cochlear hair cell differentiation.
Qin T; Ho CC; Wang B; Hui CC; Sham MH
Proc Natl Acad Sci U S A; 2022 Oct; 119(43):e2206571119. PubMed ID: 36252002
[TBL] [Abstract][Full Text] [Related]
8. S119N Mutation of the E3 Ubiquitin Ligase SPOP Suppresses SLC7A1 Degradation to Regulate Hepatoblastoma Progression.
He W; Zhang J; Liu B; Liu X; Liu G; Xie L; He J; Wei M; Li K; Ma J; Dong R; Ma D; Dong K; Ye M
Mol Ther Oncolytics; 2020 Dec; 19():149-162. PubMed ID: 33209975
[TBL] [Abstract][Full Text] [Related]
9. SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer.
Jin X; Wang J; Li Q; Zhuang H; Yang J; Lin Z; Lin T; Lv Z; Shen L; Yan C; Zheng J; Zhu J; Gong Z; Wang C; Gao K
Am J Cancer Res; 2019; 9(12):2797-2812. PubMed ID: 31911863
[TBL] [Abstract][Full Text] [Related]
10. BTB domain-containing speckle-type POZ protein (SPOP) serves as an adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase.
Kwon JE; La M; Oh KH; Oh YM; Kim GR; Seol JH; Baek SH; Chiba T; Tanaka K; Bang OS; Joe CO; Chung CH
J Biol Chem; 2006 May; 281(18):12664-72. PubMed ID: 16524876
[TBL] [Abstract][Full Text] [Related]
11. Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer.
Guo ZQ; Zheng T; Chen B; Luo C; Ouyang S; Gong S; Li J; Mao LL; Lian F; Yang Y; Huang Y; Li L; Lu J; Zhang B; Zhou L; Ding H; Gao Z; Zhou L; Li G; Zhou R; Chen K; Liu J; Wen Y; Gong L; Ke Y; Yang SD; Qiu XB; Zhang N; Ren J; Zhong D; Yang CG; Liu J; Jiang H
Cancer Cell; 2016 Sep; 30(3):474-484. PubMed ID: 27622336
[TBL] [Abstract][Full Text] [Related]
12. The CUL3-SPOP-DAXX axis is a novel regulator of VEGFR2 expression in vascular endothelial cells.
Sakaue T; Sakakibara I; Uesugi T; Fujisaki A; Nakashiro KI; Hamakawa H; Kubota E; Joh T; Imai Y; Izutani H; Higashiyama S
Sci Rep; 2017 Feb; 7():42845. PubMed ID: 28216678
[TBL] [Abstract][Full Text] [Related]
13. G3BP1 modulates SPOP to promote prostate tumorigenesis.
Mukhopadhyay C; Zhou P
Mol Cell Oncol; 2022; 9(1):2030171. PubMed ID: 35252555
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into the SPOP E3 ubiquitin ligase: From the regulation of molecular mechanisms to tumorigenesis.
Li XM; Wu HL; Xia QD; Zhou P; Wang SG; Yu X; Hu J
Biomed Pharmacother; 2022 May; 149():112882. PubMed ID: 35364375
[TBL] [Abstract][Full Text] [Related]
15. Dual Regulatory Functions of SUFU and Targetome of GLI2 in SHH Subgroup Medulloblastoma.
Yin WC; Satkunendran T; Mo R; Morrissy S; Zhang X; Huang ES; Uusküla-Reimand L; Hou H; Son JE; Liu W; Liu YC; Zhang J; Parker J; Wang X; Farooq H; Selvadurai H; Chen X; Ngan ES; Cheng SY; Dirks PB; Angers S; Wilson MD; Taylor MD; Hui CC
Dev Cell; 2019 Jan; 48(2):167-183.e5. PubMed ID: 30554998
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex.
Kim B; Nam HJ; Pyo KE; Jang MJ; Kim IS; Kim D; Boo K; Lee SH; Yoon JB; Baek SH; Kim JH
Biochem Biophys Res Commun; 2011 Dec; 415(4):720-6. PubMed ID: 22085717
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Biological Evaluation of β-Lactam Derivatives Targeting Speckle-Type POZ Protein (SPOP).
Zhou C; Hao X; Chen Z; Zhang R; Zhou Q; Fan Z; Zheng M; Hou H; Zhang S; Guo H
ACS Med Chem Lett; 2024 Feb; 15(2):270-279. PubMed ID: 38352842
[TBL] [Abstract][Full Text] [Related]
18. SPOP promotes CREB5 ubiquitination to inhibit MET signaling in liver cancer.
Gong DA; Zhou P; Chang WY; Yang JY; Zhang YL; Huang AL; Tang N; Wang K
Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119642. PubMed ID: 37996058
[TBL] [Abstract][Full Text] [Related]
19. Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6.
Tan Y; Ci Y; Dai X; Wu F; Guo J; Liu D; North BJ; Huo J; Zhang J
Oncotarget; 2017 Jul; 8(29):47890-47901. PubMed ID: 28599312
[TBL] [Abstract][Full Text] [Related]
20. SPOP and cancer: a systematic review.
Clark A; Burleson M
Am J Cancer Res; 2020; 10(3):704-726. PubMed ID: 32266086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
